KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Gains from Sales and Divestitures (2016 - 2024)

Historic Gains from Sales and Divestitures for Dynavax Technologies (DVAX) over the last 12 years, with Q2 2024 value amounting to $1.7 million.

  • Dynavax Technologies' Gains from Sales and Divestitures rose 2266.01% to $1.7 million in Q2 2024 from the same period last year, while for Jun 2024 it was $1.7 million, marking a year-over-year increase of 2266.01%. This contributed to the annual value of $1.5 million for FY2023, which is 2677.82% up from last year.
  • Dynavax Technologies' Gains from Sales and Divestitures amounted to $1.7 million in Q2 2024, which was up 2266.01% from $1.6 million recorded in Q1 2024.
  • Dynavax Technologies' 5-year Gains from Sales and Divestitures high stood at $1.7 million for Q2 2024, and its period low was $533000.0 during Q1 2021.
  • Over the past 5 years, Dynavax Technologies' median Gains from Sales and Divestitures value was $1.1 million (recorded in 2020), while the average stood at $1.1 million.
  • In the last 5 years, Dynavax Technologies' Gains from Sales and Divestitures crashed by 5285.34% in 2021 and then skyrocketed by 12253.26% in 2022.
  • Dynavax Technologies' Gains from Sales and Divestitures (Quarter) stood at $1.1 million in 2020, then plummeted by 52.85% to $537000.0 in 2021, then soared by 122.53% to $1.2 million in 2022, then increased by 26.78% to $1.5 million in 2023, then rose by 15.05% to $1.7 million in 2024.
  • Its Gains from Sales and Divestitures was $1.7 million in Q2 2024, compared to $1.6 million in Q1 2024 and $1.5 million in Q4 2023.